BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4161769)

  • 41. Management of polycythaemia in adults with cyanotic congenital heart disease.
    Thorne SA
    Heart; 1998 Apr; 79(4):315-6. PubMed ID: 9616333
    [No Abstract]   [Full Text] [Related]  

  • 42. Metabolic acidosis in cyanotic congenital heart disease in infancy.
    Jordan SC
    Br Heart J; 1969 Nov; 31(6):797. PubMed ID: 5358180
    [No Abstract]   [Full Text] [Related]  

  • 43. Observations on the use of THAM in acute cyanotic cardiac failure.
    Trusler GA; Srouji MN; Zingg W
    Can J Surg; 1966 Jul; 9(3):280-5. PubMed ID: 5941651
    [No Abstract]   [Full Text] [Related]  

  • 44. Atypical rubeosis iridis in congenital cyanotic heart disease. Report of a case with microhaemangiomas at the pupillary margin causing spontaneous hyphaemas.
    Krarup JC
    Acta Ophthalmol (Copenh); 1977 Aug; 55(4):581-5. PubMed ID: 578365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for brain abscess in patients with congenital cyanotic heart disease.
    Takeshita M; Kagawa M; Yonetani H; Izawa M; Yato S; Nakanishi T; Monma K
    Neurol Med Chir (Tokyo); 1992 Aug; 32(9):667-70. PubMed ID: 1383854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced body iron stores and atherosclerosis in patients with cyanotic congenital heart disease.
    Mascitelli L; Pezzetta F; Goldstein MR
    Int J Cardiol; 2011 Jan; 146(1):117. PubMed ID: 20965587
    [No Abstract]   [Full Text] [Related]  

  • 47. Anopthalmia/microphthlamia-esophageal atresia association with additional features imperforate anus, choanal atresia, cyanotic heart disease.
    Herman TE; Siegel MJ
    J Perinatol; 2012 Oct; 32(10):814-6. PubMed ID: 23014387
    [No Abstract]   [Full Text] [Related]  

  • 48. Cerebral malaria in children with cyanotic heart diseases: the need for a closer look.
    Okeniyi J; Kuti B
    Congenit Heart Dis; 2008; 3(1):73-6. PubMed ID: 18373754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful selective intra-arterial thrombolytic therapy for embolic stroke in a patient with asplenia syndrome and unrepaired cyanotic congenital heart disease.
    Higashi K; Honda T; Tateno S; Kawasoe Y; Niwa K; Matsuda S; Ono J
    Congenit Heart Dis; 2006 Nov; 1(6):343-5. PubMed ID: 18377507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Coagulative Profile of Cyanotic Children Undergoing Cardiac Surgery: The Role of Whole Blood Preoperative Thromboelastometry on Postoperative Transfusion Requirement.
    Vida VL; Spiezia L; Bortolussi G; Marchetti ME; Campello E; Pittarello D; Gregori D; Stellin G; Simioni P
    Artif Organs; 2016 Jul; 40(7):698-705. PubMed ID: 26611664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iron deficiency in a patient with extreme erythrocytosis due to cyanotic congenital heart disease.
    Braun SL; Eicken A; Kaemmerer H
    Int J Cardiol; 2007 Mar; 116(2):e74-5. PubMed ID: 17097163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic hypoxemia in children with cyanotic heart disease.
    O'Brien P; Smith PA
    Crit Care Nurs Clin North Am; 1994 Mar; 6(1):215-26. PubMed ID: 8192880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Electroencephalographic changes in children with cyanotic heart defects].
    Dobrzyńska L; Narkiewicz M
    Neurol Neurochir Pol; 1971; 5(2):167-74. PubMed ID: 5576476
    [No Abstract]   [Full Text] [Related]  

  • 54. Management of grown up congenital heart disease.
    Deanfield J; Thaulow E; Warnes C; Webb G; Kolbel F; Hoffman A; Sorenson K; Kaemmer H; Thilen U; Bink-Boelkens M; Iserin L; Daliento L; Silove E; Redington A; Vouhe P; Priori S; Alonso MA; Blanc JJ; Budaj A; Cowie M; Deckers J; Fernandez Burgos E; Lekakis J; Lindahl B; Mazzotta G; Morais J; Oto A; Smiseth O; Trappe HJ; Klein W; Blömstrom-Lundqvist C; de Backer G; Hradec J; Mazzotta G; Parkhomenko A; Presbitero P; Torbicki A; ;
    Eur Heart J; 2003 Jun; 24(11):1035-84. PubMed ID: 12868424
    [No Abstract]   [Full Text] [Related]  

  • 55. Neurodevelopmental evaluation of children with cyanotic congenital heart disease.
    Yilmaz İZ; Erdur B; Ozbek E; Mese T; Karaarslan U; Genel F
    Minerva Pediatr; 2018 Aug; 70(4):365-370. PubMed ID: 26041003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case report of a parturient with cyanotic congenital heart disease palliated with a Glenn procedure.
    Wendling AL; Seller A; Peterson E
    J Clin Anesth; 2012 Nov; 24(7):586-9. PubMed ID: 23101775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NEU3 sialidase role in activating HIF-1α in response to chronic hypoxia in cyanotic congenital heart patients.
    Piccoli M; Conforti E; Varrica A; Ghiroldi A; Cirillo F; Resmini G; Pluchinotta F; Tettamanti G; Giamberti A; Frigiola A; Anastasia L
    Int J Cardiol; 2017 Mar; 230():6-13. PubMed ID: 28038803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth failure in association with congenital heart disease.
    Ehlers KH
    Pediatr Ann; 1978 Nov; 7(11):750-9. PubMed ID: 740424
    [No Abstract]   [Full Text] [Related]  

  • 59. Surgical correction of scoliosis in a child with hemostatic abnormalities secondary to cyanotic congenital heart disease.
    Bunch WH; Komp DM
    Clin Orthop Relat Res; 1972; 89():139-42. PubMed ID: 4646254
    [No Abstract]   [Full Text] [Related]  

  • 60. EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart Disease.
    Vaidya A; Flores SK; Cheng ZM; Nicolas M; Deng Y; Opotowsky AR; Lourenço DM; Barletta JA; Rana HQ; Pereira MA; Toledo RA; Dahia PLM
    N Engl J Med; 2018 Mar; 378(13):1259-1261. PubMed ID: 29601261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.